Page 4 - Dbv Technologies News Today

StockNews.com assumed coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report issued on Wednesday morning. The brokerage issued a sell rating on the stock. DBVT has been the subject of several other research reports. HC Wainwright reissued a buy rating and set a $10.00 target price on shares of DBV Technologies […]

StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a research note published on Tuesday. The brokerage issued a sell rating on the stock. A number of other brokerages have also weighed in on DBVT. HC Wainwright reaffirmed a buy rating and issued a $10.00 price objective on shares of DBV […]

StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a research note published on Tuesday. The brokerage issued a sell rating on the stock. Other equities research analysts have also recently issued reports about the company. HC Wainwright reiterated a buy rating and issued a $10.00 price target on shares of […]

StockNews.com began coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report published on Tuesday morning. The firm issued a sell rating on the stock. A number of other equities research analysts also recently issued reports on the stock. JMP Securities restated a market outperform rating and issued a $4.00 target price […]

A wearable patch could help curb severe allergic reactions to peanuts in toddlers, according to the results of a clinical trial.

DBV Technologies S.A. (NASDAQ:DBVT – Get Rating) – Stock analysts at HC Wainwright lowered their Q2 2023 earnings estimates for DBV Technologies in a research report issued on Tuesday, May 9th. HC Wainwright analyst A. Fein now forecasts that the company will post earnings per share of ($0.13) for the quarter, down from their previous […]

A new study finds an experimental skin patch shows promise to treat toddlers who are...

StockNews.com initiated coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Monday morning. The firm issued a sell rating on the stock. DBVT has been the topic of a number of other research reports. Societe Generale raised shares of DBV Technologies from a hold rating to a buy rating […]

StockNews.com initiated coverage on shares of DBV Technologies (NASDAQ:DBVT – Get Rating) in a report released on Monday morning. The brokerage issued a sell rating on the stock. A number of other equities research analysts have also commented on DBVT. HC Wainwright restated a buy rating and set a $10.00 price objective on shares of […]

DBV Technologies (NASDAQ:DBVT – Get Rating) and Solid Biosciences (NASDAQ:SLDB – Get Rating) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, dividends, risk, institutional ownership, earnings, analyst recommendations and profitability. Profitability This table compares DBV Technologies and Solid Biosciences’ […]